These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 35549861)

  • 1. One-Pot Synthesis of Novel Hydrazono-1,3-Thıazolıdın-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesıs, Bıologıcal Evaluatıon, Molecular Modelling and Admet Studıes.
    Pasha MA; Mondal S; Panigrahi N; Shetye G; Ma R; Franzblau SG; Zheng YT; Murugesan S
    Curr HIV Res; 2022; 20(3):255-271. PubMed ID: 35549861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non Nucleoside Reverse Transcriptase Inhibitors, Molecular Docking Studies and Antitubercular Activity of Thiazolidin-4-one Derivatives.
    Chitre TS; Patil SM; Sujalegaonkar AG; Asgaonkar KD; Khedkar VM; Garud DR; Jha PC; Gaikwad SY; Kulkarni SS; Choudhari A; Sarkar D
    Curr Comput Aided Drug Des; 2019; 15(5):433-444. PubMed ID: 30574853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 2-arylthiazolidin-4-one-thiazole hybrids with potent activity against Mycobacterium tuberculosis.
    Othman DIA; Hamdi A; Abdel-Aziz MM; Elfeky SM
    Bioorg Chem; 2022 Jul; 124():105809. PubMed ID: 35447406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
    Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
    Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting HIV-TB coinfection by developing novel piperidin-4-substituted imines: Design, synthesis, in vitro and in silico studies.
    Kumar A; Revathi R; Sriram D; Curreli F; Debnath AK; Pai KS; Kini SG
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800358. PubMed ID: 31066103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents.
    Modi P; Patel S; Chhabria M
    Bioorg Chem; 2019 Jun; 87():240-251. PubMed ID: 30908967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies.
    Hassan NW; Saudi MN; Abdel-Ghany YS; Ismail A; Elzahhar PA; Sriram D; Nassra R; Abdel-Aziz MM; El-Hawash SA
    Bioorg Chem; 2020 Mar; 96():103610. PubMed ID: 32028062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.
    Kumar G; Krishna VS; Sriram D; Jachak SM
    Eur J Med Chem; 2018 Aug; 156():871-884. PubMed ID: 30056283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinoline derivatives as potential anti-tubercular agents: Synthesis, molecular docking and mechanism of action.
    Liu CX; Zhao X; Wang L; Yang ZC
    Microb Pathog; 2022 Apr; 165():105507. PubMed ID: 35354076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-pot synthesis, spectral characterization, biological evaluation, molecular docking studies and in silico ADME/Tox profiling of new 2,4,5 triaryl imidazole derivatives as anti tubercular agents.
    Munnaluri RK; Chevula J; Patnam N; Yamini L; Manga V
    Indian J Tuberc; 2023 Oct; 70(4):451-459. PubMed ID: 37968051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis and Biological Evaluation of Anti-tuberculosis Agents based on Bedaquiline Structure.
    Wu C; Luo J; Wu M; Meng F; Cai Z; Chen Y; Sun T
    Med Chem; 2020; 16(5):703-714. PubMed ID: 31203803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel quinazolinyl-bisspirooxindoles as potent anti-tubercular agents: an ultrasound-promoted methodology.
    Allaka BS; Basavoju S; Madhu Rekha E; Sriram D; Rama Krishna G
    Mol Divers; 2023 Jun; 27(3):1427-1436. PubMed ID: 35933454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of novel quinoline-based carboxylic hydrazides as anti-tubercular agents.
    Chander S; Ashok P; Cappoen D; Cos P; Murugesan S
    Chem Biol Drug Des; 2016 Oct; 88(4):585-91. PubMed ID: 27203404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and characterization of ethyl 3-benzoyl-7-morpholinoindolizine-1-carboxylate as anti-tubercular agents: In silico screening for possible target identification.
    Tiwari P; Mangubhai GS; Kidwai S; Singh R; Chandrashekharappa S
    Chem Biol Drug Des; 2024 Apr; 103(4):e14512. PubMed ID: 38570316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of New 3-Arylaminophthalides and 3-Indolyl-phthalides using Ammonium Chloride, Evaluation of their Anti-Mycobacterial Potential and Docking Study.
    Patil A; Duggal H; Bagul KT; Kamble S; Lokhande P; Gacche R; Meshram R
    Comb Chem High Throughput Screen; 2020; 23(8):723-739. PubMed ID: 32321396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis and Biological Evaluation of Novel Spiro-[Chroman-2,4'-Piperidin]-4-One Analogs as Anti-Tubercular Agents.
    Chitti S; Nandikolla A; Khetmalis YM; Van Calster K; Kumar BVS; Kumar BK; Murugesan S; Cappoen D; Sekhar KVGC
    Chem Biodivers; 2022 Aug; 19(8):e202200304. PubMed ID: 35821618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound Assisted Synthesis of 4-(Benzyloxy)-
    Nimbalkar UD; Seijas JA; Borkute R; Damale MG; Sangshetti JN; Sarkar D; Nikalje APG
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30081525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tubercular Modelling via QSAR Approach, In Silico Design and Virtual Docking Screening of Designed Hypothetical Inhibitors Against DNA gyrase Protein.
    Adeniji SE
    Curr Comput Aided Drug Des; 2021; 17(6):739-758. PubMed ID: 32586260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents.
    Penta A; Franzblau S; Wan B; Murugesan S
    Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.